C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle

被引:46
|
作者
Orvieto, R [1 ]
Chen, R
Ashkenazi, J
Ben-Harush, A
Bar, J
Fisch, B
机构
[1] Rabin Med Ctr, Dept Obstet & Gynecol, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
BMI; C-reactive protein; follicular fluid; ovulation induction; sex steroids;
D O I
10.1093/humrep/deh089
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The aim of the present study was to determine serum and follicular fluid C-reactive protein (CRIP) levels in patients undergoing controlled ovarian hyperstimulation (COH) for IVF-embryo transfer cycle, and their possible correlation to COH variables. PATIENTS AND METHODS: The subjects were 16 consecutive patients undergoing our routine IVF long GnRH agonist protocol. Blood was drawn three times during the COH cycle: (i) the day on which adequate suppression was obtained (Day-S); (ii) the day of, or prior to HCG administration (Day-HCG); and (iii) the day of (and before) oocyte pick-up (Day-OPU). Levels of sex steroids and serum and follicular fluid CRP were compared among the three time points. Serum and follicular fluid CRP were measured with a commercial immunoturbidimetric assay. RESULTS: Serum levels of CRP were significantly higher on Day-OPU and Day-HCG than on Day-S, and significantly higher on Day-OPU than on Day-HCG. No difference was observed between follicular and serum CRP levels on Day-OPU. No significant correlations were found between serum and follicular fluid CRP, or between serum CRP-to-BMI ratio and serum sex steroid levels or IVF treatment variables. CONCLUSIONS: The significant increase in serum CRP levels during COH, especially after HCG administration, suggests that COR potentiates a state of systemic inflammation.
引用
收藏
页码:357 / 359
页数:3
相关论文
共 50 条
  • [1] C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle (vol 19, pg 357, 2004)
    Orvieto, R
    Chen, R
    Ashkenazi, J
    Ben-Haroush, A
    Bar, J
    Fisch, B
    [J]. HUMAN REPRODUCTION, 2005, 20 (10) : 2980 - 2980
  • [2] The dydrogesterone and FSH protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation in IVF/ICSI cycle
    Gurbuz, A. S.
    Gode, F.
    [J]. HUMAN REPRODUCTION, 2019, 34 : 107 - 107
  • [3] C-reactive protein as the indicator of severity in ovarian hyperstimulation syndrome
    Nowicka, Malgorzata Anna
    Fritz-Rdzanek, Anna
    Grzybowski, Wojciech
    Walecka, Irena
    Niemiec, Krzysztof Tomasz
    Jakimiuk, Artur Jacek
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2010, 26 (06) : 399 - 403
  • [4] C-reactive protein level and pregnancy rate in patients undergoing IVF/ICSI
    Arefi, Soheila
    Babashamsi, Mohammad
    Panahi, Poneh Shariat
    Saruiy, Lima Asgharpour
    Zeraati, Hojjat
    [J]. IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE, 2010, 8 (04) : 197 - 202
  • [5] The levels of C-reactive protein in women treated by IVF
    Almagor, M
    Hazav, A
    Yaffe, H
    [J]. HUMAN REPRODUCTION, 2004, 19 (01) : 104 - 106
  • [6] Cytokines in older patients undergoing IVF:: the relationship to the response to controlled ovarian hyperstimulation
    Valbuena, D
    Albert, C
    Garrido, N
    Remohí, J
    Simón, C
    Pellicer, A
    [J]. HUMAN REPRODUCTION, 1998, 13 : 248 - 249
  • [7] Liver and kidney function of patients undergoing to a controlled ovarian hyperstimulation (COH) during an in vitro fertilization (IVF) cycle
    Romito, Ilaria
    Gulino, Ferdinando A.
    Tuscano, Attilio
    Di Gregorio, L. M.
    Di Stefano, A.
    Leanza, Gianluca
    Leanza, Vito
    Palumbo, Marco A.
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 146 - 146
  • [8] Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF
    Manau, Dolors
    Fabregues, Francisco
    Penarrubia, Joana
    Creus, Montserrat
    Carmona, Francisco
    Casals, Gemma
    Jimenez, Wladimiro
    Balasch, Juan
    [J]. HUMAN REPRODUCTION, 2007, 22 (03) : 669 - 675
  • [9] The levels of C-reactive protein in women treated by IVF: Reply
    Almagor, M
    [J]. HUMAN REPRODUCTION, 2004, 19 (07)
  • [10] HIGH C-REACTIVE PROTEIN LEVELS IN WOMEN UNDERGOING IVF ARE ASSOCIATED WITH LOW QUALITY EMBRYOS.
    Herzberger, E. Haikin
    Miller, N.
    Ghetler, Y.
    Yaniv, R. Tamir
    Keren, K. Amichay
    Shulman, A.
    Wiser, A.
    [J]. FERTILITY AND STERILITY, 2016, 106 (03) : E262 - E262